200 related articles for article (PubMed ID: 16643447)
21. Is p190 bcr-abl rearrangement necessary for acute transformation in some p210 CML of childhood?
Scrideli CA; de Oliveira FM; Brassesco MS; de Paula Queiroz R; Bernardes JE; Valera ET; Tone LG
Leuk Res; 2009 Mar; 33(3):495-9. PubMed ID: 18495245
[TBL] [Abstract][Full Text] [Related]
22. NPM1 mutations occur rarely or not at all in chronic myeloid leukaemia patients in chronic phase or blast crisis.
Watkins DB; Hughes TP; White DL; D'Andrea RJ
Leukemia; 2013 Feb; 27(2):489-90. PubMed ID: 22791379
[No Abstract] [Full Text] [Related]
23. High-density single nucleotide polymorphism array analysis and ASXL1 gene mutation screening in chronic myeloid leukemia during disease progression.
Boultwood J; Perry J; Zaman R; Fernandez-Santamaria C; Littlewood T; Kusec R; Pellagatti A; Wang L; Clark RE; Wainscoat JS
Leukemia; 2010 Jun; 24(6):1139-45. PubMed ID: 20410925
[TBL] [Abstract][Full Text] [Related]
24. Aberrant expression of the LHX4 LIM-homeobox gene caused by t(1;14)(q25;q32) in chronic myelogenous leukemia in biphenotypic blast crisis.
Yamaguchi M; Yamamoto K; Miura O
Genes Chromosomes Cancer; 2003 Nov; 38(3):269-73. PubMed ID: 14506703
[TBL] [Abstract][Full Text] [Related]
25. Chronic myeloid leukemia blast crisis arises from progenitors.
Michor F
Stem Cells; 2007 May; 25(5):1114-8. PubMed ID: 17218393
[TBL] [Abstract][Full Text] [Related]
26. Telomeres and telomerase in chronic myeloid leukaemia: impact for pathogenesis, disease progression and targeted therapy.
Keller G; Brassat U; Braig M; Heim D; Wege H; Brümmendorf TH
Hematol Oncol; 2009 Sep; 27(3):123-9. PubMed ID: 19569255
[TBL] [Abstract][Full Text] [Related]
27. "Acute myelogenous leukemia like" translocations in CML blast crisis: two new cases of inv(16)/t(16;16) and a review of the literature.
Patel BB; Mohamed AN; Schiffer CA
Leuk Res; 2006 Feb; 30(2):225-32. PubMed ID: 16076492
[TBL] [Abstract][Full Text] [Related]
28. [Relationship between blast crisis of chronic myeloid leukemias and abnormality of p16 and calcitonin genes].
Xu D; Hong W; Wang S
Zhonghua Zhong Liu Za Zhi; 2000 Mar; 22(2):151-3. PubMed ID: 11776646
[TBL] [Abstract][Full Text] [Related]
29. Sudden blast crisis in patients with Philadelphia chromosome-positive chronic myeloid leukemia who achieved complete cytogenetic remission after imatinib therapy.
Alimena G; Breccia M; Latagliata R; Carmosino I; Russo E; Biondo F; Diverio D; Mancini M; Nanni M; Mandelli F
Cancer; 2006 Sep; 107(5):1008-13. PubMed ID: 16878324
[TBL] [Abstract][Full Text] [Related]
30. Expression of programmed cell death proteins in patients with chronic myeloid leukemia.
Strnad M; Brajuskovic G; Strelic N; Todoric-Zivanovic B; Stamatovic D; Tatomirovic Z; Magic Z
J BUON; 2008; 13(3):403-8. PubMed ID: 18979557
[TBL] [Abstract][Full Text] [Related]
31. Contribution of ABL kinase domain mutations to imatinib resistance in different subsets of Philadelphia-positive patients: by the GIMEMA Working Party on Chronic Myeloid Leukemia.
Soverini S; Colarossi S; Gnani A; Rosti G; Castagnetti F; Poerio A; Iacobucci I; Amabile M; Abruzzese E; Orlandi E; Radaelli F; Ciccone F; Tiribelli M; di Lorenzo R; Caracciolo C; Izzo B; Pane F; Saglio G; Baccarani M; Martinelli G;
Clin Cancer Res; 2006 Dec; 12(24):7374-9. PubMed ID: 17189410
[TBL] [Abstract][Full Text] [Related]
32. Additional clonal abnormalities in Philadelphia-positive ALL and CML demonstrate a different cytogenetic pattern at diagnosis and follow different pathways at progression.
Bacher U; Haferlach T; Hiddemann W; Schnittger S; Kern W; Schoch C
Cancer Genet Cytogenet; 2005 Feb; 157(1):53-61. PubMed ID: 15676148
[TBL] [Abstract][Full Text] [Related]
33. DNA copy number alterations mark disease progression in paediatric chronic myeloid leukaemia.
van der Sligte NE; Krumbholz M; Pastorczak A; Scheijen B; Tauer JT; Nowasz C; Sonneveld E; de Bock GH; Meeuwsen-de Boer TG; van Reijmersdal S; Kuiper RP; Bradtke J; Metzler M; Suttorp M; de Bont ES; van Leeuwen FN
Br J Haematol; 2014 Jul; 166(2):250-3. PubMed ID: 24673583
[TBL] [Abstract][Full Text] [Related]
34. Stem cell regulation and the development of blast crisis in chronic myeloid leukemia: Implications for the outcome of Imatinib treatment and discontinuation.
Wodarz D
Med Hypotheses; 2008; 70(1):128-36. PubMed ID: 17566666
[TBL] [Abstract][Full Text] [Related]
35. Expression of angiogenic factors in chronic myeloid leukaemia: role of the bcr/abl oncogene, biochemical mechanisms, and potential clinical implications.
Sillaber C; Mayerhofer M; Aichberger KJ; Krauth MT; Valent P
Eur J Clin Invest; 2004 Aug; 34 Suppl 2():2-11. PubMed ID: 15291801
[TBL] [Abstract][Full Text] [Related]
36. [Immunophenotype of blast crisis in chronic myeloid leukemia].
Favre G; Passweg J; Hoffmann T; Speck B; Gratwohl A; Tichelli A
Schweiz Med Wochenschr; 1998 Oct; 128(42):1624-6. PubMed ID: 9824896
[TBL] [Abstract][Full Text] [Related]
37. Coding sequence and intron-exon junctions of the c-myb gene are intact in the chronic phase and blast crisis stages of chronic myeloid leukemia patients.
Bussolari R; Candini O; Colomer D; Corradini F; Guerzoni C; Mariani SA; Cattelani S; Silvestri C; Pecorari L; Iacobucci I; Soverini S; Fasano T; Martinelli G; Cervantes F; Calabretta B
Leuk Res; 2007 Feb; 31(2):163-7. PubMed ID: 16797705
[TBL] [Abstract][Full Text] [Related]
38. Complexity of CEBPA dysregulation in human acute myeloid leukemia.
Pabst T; Mueller BU
Clin Cancer Res; 2009 Sep; 15(17):5303-7. PubMed ID: 19706798
[TBL] [Abstract][Full Text] [Related]
39. Aberrant methylation of the death-associated protein kinase 1 (DAPK1) CpG island in chronic myeloid leukemia.
Qian J; Wang YL; Lin J; Yao DM; Xu WR; Wu CY
Eur J Haematol; 2009 Feb; 82(2):119-23. PubMed ID: 19018866
[TBL] [Abstract][Full Text] [Related]
40. Instability of BCR-ABL gene in primary and cultured chronic myeloid leukemia stem cells.
Jiang X; Saw KM; Eaves A; Eaves C
J Natl Cancer Inst; 2007 May; 99(9):680-93. PubMed ID: 17470736
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
